NL130759C - - Google Patents

Info

Publication number
NL130759C
NL130759C NL130759DA NL130759C NL 130759 C NL130759 C NL 130759C NL 130759D A NL130759D A NL 130759DA NL 130759 C NL130759 C NL 130759C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL130759C publication Critical patent/NL130759C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL130759D 1965-10-07 NL130759C (en:Method)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB42635/65A GB1099389A (en) 1965-10-07 1965-10-07 Pharmaceutical compositions
GB1749666 1966-04-21
GB2686266 1966-06-16

Publications (1)

Publication Number Publication Date
NL130759C true NL130759C (en:Method)

Family

ID=27257509

Family Applications (2)

Application Number Title Priority Date Filing Date
NL130759D NL130759C (en:Method) 1965-10-07
NL6614130A NL6614130A (en:Method) 1965-10-07 1966-10-07

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6614130A NL6614130A (en:Method) 1965-10-07 1966-10-07

Country Status (11)

Country Link
US (2) US3538107A (en:Method)
BE (1) BE687981A (en:Method)
CH (1) CH515922A (en:Method)
DE (1) DE1695252A1 (en:Method)
DK (1) DK112733B (en:Method)
ES (1) ES331997A1 (en:Method)
FR (2) FR1509969A (en:Method)
GB (1) GB1099389A (en:Method)
IL (1) IL26603A (en:Method)
NL (2) NL6614130A (en:Method)
SE (3) SE358397B (en:Method)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1145884A (en) * 1966-11-18 1969-03-19 Wyeth John & Brother Ltd Thiazole derivatives
US3546342A (en) * 1966-11-18 1970-12-08 Wyeth John & Brother Ltd Method of relieving inflammation by administration of 2,4 - diarylthiazole- 5 - alkanoic acids and derivatives thereof
IL28803A (en) * 1966-11-18 1974-05-16 Wyeth John & Brother Ltd Oxazole and thiazole compounds,their preparation and pharmaceutical compositions containing them
IE32084B1 (en) * 1967-06-07 1973-04-04 Wyeth John & Brother Ltd Thiazole derivatives
GB1237194A (en) * 1967-10-26 1971-06-30 Wyeth John & Brother Ltd Pharmaceutical compositions containing 2-arylthiazoles
CY800A (en) * 1968-04-09 1976-12-01 Wyeth John & Brother Ltd Novel thiazoline derivatives, the preparation thereof and compositions containing the same
FR2035757A1 (en) * 1969-02-25 1970-12-24 Roussel Uclaf Novel 4-carboxy-4,5,6,7-tetrahydro benzothia- - zole derivs
US3898340A (en) * 1970-04-15 1975-08-05 Bayer Ag Aryliminothiazolidine compositions and methods
FR2334353A1 (fr) * 1975-12-12 1977-07-08 Roussel Uclaf Nouveaux derives thiazoliques, un procede pour leur preparation et leur application comme medicaments
US4197306A (en) * 1977-06-30 1980-04-08 Uniroyal, Inc. Aryl-substituted thiazoles
US4153703A (en) * 1977-06-30 1979-05-08 Uniroyal, Inc. Method of controlling insects and acarids with certain aryl-substituted thiazoles
GR74148B (en:Method) * 1980-04-03 1984-06-06 Wyeth John & Brother Ltd
FR2500452A1 (fr) * 1981-02-26 1982-08-27 Roussel Uclaf Alcools heterocycliques et derives fonctionnels, ainsi que leur procede de preparation
US4600025A (en) * 1982-11-18 1986-07-15 Grigg Ronald E Smoking products comprising nicotine substitutes
GB8826035D0 (en) * 1988-11-07 1988-12-14 Ici Plc Herbicidal compositions
US5182402A (en) * 1988-11-07 1993-01-26 Imperial Chemical Industries Plc Herbicidal compositions
DE3941438A1 (de) * 1989-12-15 1991-06-20 Hoechst Ag Neue 2-substituierte 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US5077305A (en) * 1990-02-13 1991-12-31 Bristol-Myers Squibb Co. Thiazole carboxylic acids and esters
CA2036192A1 (en) 1990-02-13 1991-08-14 Nicholas Meanwell Heterocyclic carboxylic acids and esters
US5451397A (en) * 1992-12-21 1995-09-19 Rohm And Haas Company Bile acid sequestrant
US5498678A (en) * 1992-12-21 1996-03-12 Rohm And Haas Company Suspension polymerization process for water-soluble monomers
DE10029077A1 (de) * 2000-06-13 2001-12-20 Bayer Ag Thiazolylsubstituierte Heterocyclen
DE10100175A1 (de) * 2001-01-04 2002-07-11 Bayer Ag Hetarylsubstituierte Homotetram-und Homotetronsäuren
DE10118310A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Hetarylsubstituierte carbocyclische 1,3-Dione
HUP0303829A3 (en) * 2001-04-16 2006-02-28 Tanabe Seiyaku Co Large conductance calcium-acitvated k channel opener compounds, use thereof and pharmaceutical compositions containing them
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
DE10331675A1 (de) 2003-07-14 2005-02-10 Bayer Cropscience Ag Hetarylsubstituierte Pyrazolidindion-Derivate
US7521563B2 (en) * 2004-08-10 2009-04-21 Shizuoka Coffein Co., Ltd. Hydroxamic acid derivative and medicine containing the same as active ingredient
JOP20130273B1 (ar) 2012-09-11 2021-08-17 Genzyme Corp مثبطات انزيم (سينثاز) غلوكوسيل سيراميد
CN108658970A (zh) * 2013-03-15 2018-10-16 建新公司 制备葡萄糖基神经酰胺合酶抑制剂的方法
US11091451B2 (en) * 2016-12-05 2021-08-17 Raze Therapeutics, Inc. SHMT inhibitors and uses thereof
MX2020009813A (es) * 2018-03-29 2020-11-11 Lumosa Therapeutics Co Ltd Composiciones y metodos para tratar el prurito.
WO2019207548A1 (en) * 2018-04-27 2019-10-31 Ahammune Biosciences Private Limited Process for preparing a potent thiazole compound, pharmaceutical formulation and uses thereof
PT3920912T (pt) 2019-02-04 2025-09-09 Genzyme Corp Tratamento de ciliopatias usando inibidores da glucosilceramida sintase (gcs)
GB2581502A (en) * 2019-02-19 2020-08-26 Univ Bristol Solidification or crystallisation method
EP4100009A1 (en) 2020-02-03 2022-12-14 Genzyme Corporation Methods for treating neurological symptoms associated with lysosomal storage diseases
CA3186766A1 (en) 2020-07-24 2022-01-27 Danielle Combessis Pharmaceutical compositions comprising venglustat

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2020650A (en) * 1932-08-18 1935-11-12 Winthrop Chem Co Inc Thiazole substituted by a primary alkylamino group

Also Published As

Publication number Publication date
SE346112B (en:Method) 1972-06-26
US3538107A (en) 1970-11-03
FR1509969A (fr) 1968-01-19
DK112733B (da) 1969-01-13
NL6614130A (en:Method) 1967-04-10
BE687981A (en:Method) 1967-04-07
ES331997A1 (es) 1967-10-16
SE358397B (en:Method) 1973-07-30
US3749787A (en) 1973-07-31
GB1099389A (en) 1968-01-17
FR6190M (en:Method) 1968-07-22
CH515922A (de) 1971-11-30
SE364049B (en:Method) 1974-02-11
IL26603A (en) 1970-11-30
DE1695252A1 (de) 1971-03-18

Similar Documents

Publication Publication Date Title
FR6190M (en:Method)
FR6139M (en:Method)
FI43434B (en:Method)
JPS4311753Y1 (en:Method)
JPS4723756Y1 (en:Method)
JPS4521512Y1 (en:Method)
AU6340065A (en:Method)
BE675251A (en:Method)
BE675127A (en:Method)
BE663720A (en:Method)
BE663662A (en:Method)
NL6513683A (en:Method)
BE661207A (en:Method)
NL6609888A (en:Method)
BE658840A (en:Method)
BE684669A (en:Method)
BE675396A (en:Method)
BE675274A (en:Method)
BE675273A (en:Method)
BE674710A (en:Method)
BE675209A (en:Method)
BE675185A (en:Method)
AU6882465A (en:Method)
BE664290A (en:Method)
BE675110A (en:Method)